e2v to Establish Next Generation Biosensor System Using AbD Serotec-generated HuCAL Antibodies

AbD Serotec, the division for research and diagnostic antibodies of MorphoSys AG, and its customer e2v biosensors, a subsidiary of e2v technologies plc, today launched a research program to establish e2v’s proprietary biosensor system Visucare™, a novel detection technology for biomarkers using a single-antibody immunoassay. The Visucare™ system will be used for protein quantification in point of care and near patient testing.

AbD Serotec